Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated drugs:
    Italy
  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    3 1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland Germany Italy The Netherlands Poland
  • Study on Upadacitinib and Tocilizumab for Children and Teens with Active Systemic Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Germany Hungary Italy The Netherlands +2
  • Study on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency

    Recruiting

    4 1 1
    Austria Bulgaria Czechia France Germany Hungary +8
  • Study on Ureter Imaging with Nizaracianine Triflutate for Patients 18+ Undergoing Abdominopelvic Surgery

    Recruiting

    4 1 1
    Investigated drugs:
    The Netherlands
  • Study on the Effect of Influenza Vaccine on Heart Inflammation After Heart Attack for Patients with Myocardial Infarction

    Recruiting

    3 1 1
    Investigated diseases:
    Denmark Sweden
  • Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated drugs:
    Sweden
  • Study on CAR-T-cell Therapy with Rituximab and Ibrutinib for Patients with High-Risk Mantle Cell Lymphoma

    Recruiting

    2 1 1 1
    Czechia France Germany The Netherlands Spain